Anticancer agents targeted to sirtuins

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Aging Research

Background:

• Sirtuins are a class of nicotinamide adenine dinucleotide+-dependent deacetylases with seven isoforms (SIRT1-7).
• Sirtuin activity influences critical cellular processes including gene expression, aging, and neurodegeneration.
• Emerging evidence links sirtuins to both anti-aging effects and cancer development, contingent on specific cellular targets and pathways.

Purpose of the Study:

• To review the role of sirtuins, particularly SIRT1 and SIRT2, as potential therapeutic targets in cancer.
• To explore the therapeutic potential of small molecule sirtuin modulators in cancer prevention and treatment.
• To enhance understanding of sirtuin biological functions and molecular mechanisms through modulator studies.

Main Methods:

• Literature review of studies investigating sirtuin isoforms (SIRT1-7) and their functions.
• Analysis of research on small chemical compounds that modulate sirtuin activity.
• Focus on studies examining the link between sirtuins, particularly SIRT1 and SIRT2, and cancer.

Main Results:

• Sirtuin activity is implicated in diverse biological processes, including aging and age-related diseases.
• Sirtuins play a dual role in tumorigenesis, potentially promoting or inhibiting cancer depending on context.
• Sirtuin modulators have proven valuable in elucidating sirtuin functions and mechanisms.

Conclusions:

• Sirtuins, especially SIRT1 and SIRT2, represent promising targets for novel cancer therapies.
• Sirtuin modulators offer significant therapeutic potential for both the prevention and treatment of cancer.
• Further research into sirtuin modulators could lead to innovative anti-cancer strategies.